Source: International Journal of Biological Macromolecules. Unidade: FCFRP
Subjects: FÁRMACOS IMUNOSSUPRESSORES, ENVENENAMENTO, PICADAS EM ANIMAL, COBRAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WIEZEL, Gisele Adriano et al. Hyperglycosylation impairs the inhibitory activity of rCdtPLI2, the first recombinant beta-phospholipase A2 inhibitor. International Journal of Biological Macromolecules, v. 280, n. Pt2, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2024.135581. Acesso em: 12 fev. 2026.APA
Wiezel, G. A., Oliveira, I. S. de, Ferreira, I. G., Bordon, K. de C. F., & Arantes, E. C. (2024). Hyperglycosylation impairs the inhibitory activity of rCdtPLI2, the first recombinant beta-phospholipase A2 inhibitor. International Journal of Biological Macromolecules, 280( Pt2). doi:10.1016/j.ijbiomac.2024.135581NLM
Wiezel GA, Oliveira IS de, Ferreira IG, Bordon K de CF, Arantes EC. Hyperglycosylation impairs the inhibitory activity of rCdtPLI2, the first recombinant beta-phospholipase A2 inhibitor [Internet]. International Journal of Biological Macromolecules. 2024 ;280( Pt2):[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.ijbiomac.2024.135581Vancouver
Wiezel GA, Oliveira IS de, Ferreira IG, Bordon K de CF, Arantes EC. Hyperglycosylation impairs the inhibitory activity of rCdtPLI2, the first recombinant beta-phospholipase A2 inhibitor [Internet]. International Journal of Biological Macromolecules. 2024 ;280( Pt2):[citado 2026 fev. 12 ] Available from: https://doi.org/10.1016/j.ijbiomac.2024.135581
